Establishing of a risk prediction model for metabolic dysfunction-associated steatotic liver disease: a retrospective cohort study

This is the authors' abstract. We don't add key points for this paper.

The model may provide clinical physicians with a reliable method for identifying high-risk populations for MASLD and serve as a guide for developing prediction models for other diseases.